New animal reproductive material health requirements: bluetongue, EHD and equine metritis

Key data

If you market semen, eggs or embryos of animals within the EU—or import them from third countries—this regulation changes the rules of the game. The Delegated Regulation (EU) 2026/794, published on 7 August 2026, amends Regulation (EU) 2020/686 to strengthen health controls against the geographic spread of three animal diseases in Europe. Non-compliance is not a minor administrative matter: it can result in a complete restriction on intra-community trade in your reproductive material.

What does this regulation establish?

The regulation amends Regulation (EU) 2020/686, which regulates the movement of animal reproductive material in the EU. The changes focus on three diseases whose geographic expansion in Europe has forced stricter controls:

In practice, the regulation acts on two levers: certification requirements (what documents and health guarantees must accompany the reproductive material) and movement conditions (what controls apply both to exchanges between Member States and to imports from third countries). The stated objective is to harmonize preventive measures against the spread of these diseases in European territory.

Economic and operational impact

The regulation does not set direct financial penalties or specific amounts, but its operational consequences are significant:

• Restrictions on intra-community trade: Non-compliance with the new requirements can completely block the sale or transfer of semen, eggs and embryos between EU countries. For reproduction centers with customers in several Member States, this amounts to losing market immediately.
• Adaptation of health protocols: Operators will need to review and update their internal control procedures for the three regulated diseases, which involves veterinary costs, testing and document management.
• New certification documentation: Each movement of reproductive material must be accompanied by updated certification in accordance with the new requirements, adding administrative burden to each commercial transaction.
• Imports from third countries: The conditions for entry of reproductive material from outside the EU are also tightened, affecting importers and reproduction centers working with non-EU genetic material.

Who does it affect?

• Livestock farmers who use or market semen, eggs or embryos of cattle, sheep or goats within the EU.
• Equine breeders (horses, ponies, donkeys) who work with reproductive material and carry out movements between EU countries.
• Animal reproduction centers (semen collection and storage centers, embryo collection teams) operating under the framework of Regulation (EU) 2020/686.
• Veterinarians responsible for health certification of reproductive material.
• Importers of reproductive material from third countries.
• Advisors and managers of livestock farms or equestrian centers with cross-border reproductive activity.

Practical example

A bovine artificial insemination center located in Spain that exports bull semen to France, Portugal and Germany currently operates under the requirements of Regulation (EU) 2020/686. With the entry into force of Regulation 2026/794, each batch of semen must be accompanied by the new health certification that proves compliance with specific requirements for bluetongue (serotypes 1-24) and EHD.

If the center does not update its health control protocol and certification documentation, the competent authorities in the destination country may reject the batch at the border or at the control point, blocking the commercial transaction. For a center managing dozens of shipments monthly to different Member States, the operational and economic impact of a blockade can be immediate and significant.

In the equine sector, a sport horse breeder who imports stallion semen from a third country (for example, the United States) must verify that the material complies with the new requirements regarding equine contagious metritis caused by Taylorella equigenitalis, including the documentation required at source.

What should companies do now?

1. Identify if your activity is affected: Review whether you market, store or import semen, eggs or embryos of ruminants or equids with movements between Member States or from third countries.
2. Review current health protocols: Compare your current procedures with the new requirements of Regulation 2026/794 for the three regulated diseases (bluetongue serotypes 1-24, EHD and equine contagious metritis).
3. Update certification documentation: Work with your responsible veterinarian to adapt the health certificates that accompany each movement of reproductive material.
4. Contact the competent authority: Consult with the Ministry of Agriculture or the corresponding regional authority to learn about adaptation timelines and updated certification models.
5. Review contracts with customers and suppliers: If you have supply agreements for reproductive material with operators in other Member States or third countries, verify that the new health conditions are covered.
6. Train staff: Ensure that the veterinary and administrative team is aware of the new requirements before the effective application date.

Official source

Consult complete regulation at official source

Notice: This article is for informational purposes only and does not constitute legal advice. For specific decisions, consult a qualified professional. Source: https://eur-lex.europa.eu/./legal-content/AUTO/?uri=CELEX:32026R0794